Domantis Ltd.
Cambridge
About Domantis Ltd.
Domantis Ltd. develops antibody molecules. Domantis Ltd. offers dual targeting human domain antibodies, which are used against cytokine targets for inflammatory diseases, tumour antigens present on the same tumour cells, and tumour growth/angiogenic factors for solid tumours; human domain antibodies with tailored serum half-life that are customized to achieve the desired therapeutic effect; human domain antibodies for diverse therapeutic targets, which are suited to inhibit receptor targets; and injectable and non-injectable human domain antibodies that treat diseases of the lung, as well as disorders of the gastro-intestinal tract.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: M&A
- Last round: Private Equity (Jan 2004)
- Phone: +44 1223 226900
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/domantis-ltd-2849796 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.